Physician profile
Bassam C Saliba
NPI 1861412223
$3,375.32
in general payments reported to CMS, 2019-2025
16 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,214 · 2020: $26.72 · 2021: $72.03 · 2022: $15.18 · 2023: $1,107 · 2024: $412 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241 · Travel and Lodging: $737 · Education: $70.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.50 |
| Travel and Lodging | $737.04 |
| Education | $70.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,118.11 | 2021-2025 | Selectsecure, Aurora Ev-Icd Mri Surescan, Micra |
| Medtronic Vascular, INC. | $743.49 | 2019 | |
| Boston Scientific Corporation | $674.24 | 2023-2025 | Cds Broad Portfolio Offering, Opticross 6, Ffr Link |
| Edwards Lifesciences Corporation | $348.11 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $131.14 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $81.43 | 2023-2024 | Lifevest |
| Abiomed | $55.77 | 2021-2025 | |
| Abbott Laboratories | $50.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.53 | 2021-2025 | Eliquis, Camzyos |
| Asahi Intecc USA, INC. | $25.56 | 2024 | Peripheral Vascular |
| Stryker Corporation | $22.11 | 2025 | Triever20 |
| Inari Medical, INC. | $20.44 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lundbeck LLC | $16.27 | 2019 | |
| Philips North America LLC | $15.42 | 2020 | |
| Merck Sharp & Dohme LLC | $15.18 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassam Saliba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.